Clinical trial

Argipressin's Influence on Blood Loss During Hepatic Resection

NCT05293041

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-03-27

PhasePHASE4

Study timeline

Study start (actual)2022-03-27Date precision: day

Registry last updated2025-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Colon Cancer Liver Metastasisunresolved

Inflammatory Responseunresolved

Vasopressin Causing Adverse Effects in Therapeutic Useunresolved

Interventions

ArgipressinDRUG · verified · RxNorm: argipressin

PlaceboDRUG

Sponsors & collaborators

Kristina Svennerholmlead sponsor

Mapped research locations

GothenburgSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05293041 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.